A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2007
12/05/2007	CN101081049A Green grape health tea
12/05/2007	CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis
12/05/2007	CN100352921C Compositions and methods for identifying antigens which elicit an immune response
12/05/2007	CN100352908C Liver-nourishing and antilipemic wine and production thereof
12/05/2007	CN100352843C Kdr peptides and vaccines comprising the same
12/05/2007	CN100352839C Method for preparing insect protein with blood-fat reducing function
12/05/2007	CN100352816C Nociceptin analogs
12/05/2007	CN100352807C Chemical compounds
12/05/2007	CN100352505C A combination of FBPase Inhibitors and insulin sensitizers for the treatment of diabetes
12/05/2007	CN100352504C Nutritious supplementing agent contg. a-glucosidase inhibitor and a-amylase inhibitor
12/05/2007	CN100352502C Recombinant protein and recombinant gene capable of preventing and curing I type diabetes mellitus through immunity
12/05/2007	CN100352499C High mannose proteins and method of making mannose proteins
12/05/2007	CN100352492C Health care medicinal pillow
12/05/2007	CN100352491C Fat-reducing tea and preparation method trereof
12/05/2007	CN100352484C Medicine for diabetes and its preparation
12/05/2007	CN100352478C Novel use of bighead atractylodes rhizome in pharmacy
12/05/2007	CN100352473C Tea and Chinese wolfberry fruit extracts composition and use thereof
12/05/2007	CN100352457C Apocynum extract and extracting method thereof
12/05/2007	CN100352449C Medicament composition for treating tinea pedis and tinea corporis
12/05/2007	CN100352439C Compound nicotinic acid slow releasing capsule and its preparing method
12/05/2007	CN100352432C Nateglinide-containing preparation
12/05/2007	CN100352374C Satiety inducing composition
12/04/2007	US7304174 CaSR antagonist
12/04/2007	US7304167 Biphenylcarboxamides useful as lipid lowering agents
12/04/2007	US7304166 (2S,4S)-2-Cyano-4-fluoro-1-[(2-hydroxy-1,1-dimethyl)ethylamino]acetylpyrrolidine benzenesulfonate; dipeptidyl peptidase IV inhibitors with high-purity uniform crystal form and excellent solid-state stability
12/04/2007	US7304156 Preparation of aminopyrimidine compounds
12/04/2007	US7304091 Statin-like compounds
12/04/2007	US7304089 Preparation for improved dietary utilisation
12/04/2007	US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007	US7304079 Preparing 3-benzothiazolylalkyl-1-indolylacetic acids and esters by cyclizing a 3-(anilinothiocarbonylalkyl)-1-indolylacetic ester with potassium ferricyanide or sodium hydride, optionally deprotecting the acid group; aldose reductase inhibitors for diabetic complications; side effect reduction
12/04/2007	US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007	US7304072 Spiro compounds
12/04/2007	US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007	US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007	US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007	US7304053 Glycoprotein-mediated MDR
12/04/2007	US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
12/04/2007	US7304029 Inducing a neuroprotective effect of rescuing neurons destined to degenerate or die as a result of hypoxia or ischemia in a brain of a patient by administering growth hormone centrally to the brain of the patient
12/04/2007	US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein
12/04/2007	US7303765 Ultrafine-L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
12/04/2007	US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
12/04/2007	CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007	CA2383140C Ppar.alpha. and ppar.gamma. inhibitors
12/04/2007	CA2345622C Tricyclic .delta.3-piperidines as .alpha.2-antagonists
12/04/2007	CA2193097C Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
11/2007
11/29/2007	WO2007137098A2 Sulfonyl-substituted bicyclic compounds as modulators of ppar
11/29/2007	WO2007136696A2 Use of substituted azetidinone compounds with cetp inhibitors for the treatment of sitosterolemia
11/29/2007	WO2007136116A2 C-phenyl glycitol compound for the treatment of diabetes
11/29/2007	WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy
11/29/2007	WO2007135767A1 Guava leaf extract powder and method for production thereof
11/29/2007	WO2007135427A1 1,4-disubstituted piperazine and 1,4-disubstituted azepane as 11 -beta-hydroxysteroid dehydrogenase 1 inhibitors
11/29/2007	WO2007135294A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
11/29/2007	WO2007135141A1 Maternal supplement
11/29/2007	WO2007135118A1 Soluble, stable insulin-containing formulations
11/29/2007	WO2007135111A1 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament
11/29/2007	WO2007134986A1 Pyridopyrimidinone derivatives
11/29/2007	WO2007134958A1 Thiazolo-pyramidine / pyridine urea derivatives as adenosine a2b receptor antagonists
11/29/2007	WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application
11/29/2007	WO2007134460A1 Pancreatic b-cells expressing abca1 and uses thereof
11/29/2007	WO2007134457A1 Cyclic amine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
11/29/2007	WO2007117563A3 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof
11/29/2007	WO2007114945A3 Compositions and methods for enhancing the antioxidant status of animals
11/29/2007	WO2007114855A3 Glucagon receptor antagonists, preparation and therapeutic uses
11/29/2007	WO2007112914A3 Ceramide kinase modulation
11/29/2007	WO2007112204A3 Ingestible compositions containing extracts
11/29/2007	WO2007101021A3 Humanized anti-ghrelin antibodies
11/29/2007	WO2007098964A3 Pyrrazole derivatives as sigma receptors antagonists
11/29/2007	WO2007090087A3 Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
11/29/2007	WO2007014619A8 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/29/2007	WO2006138572A3 Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
11/29/2007	US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007	US20070276043 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity
11/29/2007	US20070276029 Glutamine-Containing Energy Imparting Amino Acid Composition or Amino Acid Solution
11/29/2007	US20070276027 Crystalline Forms of [R-(R* ,R*)]-2-(4-Fluorophenyl)-Beta, -Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid
11/29/2007	US20070276025 Indirubin-Type Compounds, Compositions, and Methods for Their Use
11/29/2007	US20070276012 Process for Preparing Thiazolidinediones
11/29/2007	US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007	US20070276001 Biphenyl-pyrazolecarboxamide compounds
11/29/2007	US20070275979 Novel Compounds
11/29/2007	US20070275973 Aryl fused azapolycyclic compounds
11/29/2007	US20070275970 Compositions for affecting weight loss
11/29/2007	US20070275964 Cannabinoid receptor ligands and uses thereof
11/29/2007	US20070275956 Novel Heterocyclic Compounds
11/29/2007	US20070275950 2-Phenylpyridine Derivative
11/29/2007	US20070275928 Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
11/29/2007	US20070275914 Therapeutic Compositions
11/29/2007	US20070275910 Phosphoramidate Derivatives
11/29/2007	US20070275893 Compositions for enhanced epithelial permeation of peptide yy for treating obesity
11/29/2007	US20070275877 Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
11/29/2007	US20070275054 Novel composition and use
11/29/2007	US20070274998 Novel Bispecific Molecules For Use In Therapy And Diagnosis
11/29/2007	US20070274993 Immunocompetent Cell Activation Inhibitor and Use Thereof
11/29/2007	US20070274981 Fibroblast Growth Factor Receptor-1 Inhibitors and Methods of Treatment Thereof
11/29/2007	US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/29/2007	US20070274913 Preventives/Remedies for Stress Urinary Incontinence and Method of Screening the Same
11/29/2007	US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
11/29/2007	CA2752585A1 Delivery of active agents using a chocolate vehicle
11/29/2007	CA2752530A1 Delivery of active agents using a chocolate vehicle
11/29/2007	CA2752522A1 Delivery of active agents using a chocolate vehicle
11/29/2007	CA2653091A1 Maternal supplement comprising docosahexaenoic acid to prevent obesity in infants and children

1 ... 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 ... 1298